Detection Kit for Neutralization Antibody of SARS-CoV-2 (Competitive ELISA)

For Research Use Only. Not for use in diagnostic procedures.

Product Description

The Detection Kit for Neutralization Antibody of SARS-CoV-2 is a competitive Enzyme-Linked Immunosorbent Assay (ELISA) intended for detection of total neutralization antibodies to SARS-CoV-2 in serum/plasma. The receptor-binding domain (RBD) of the SARS-CoV-2 S protein, which is responsible for recognizing the cell surface receptor, angiotensin-converting enzyme-2 (ACE2). Current research indicates that the RBD strongly interacts with the human ACE2 receptor, leading to endocytosis of the virus into the host cells of the deep lung and viral replication.

Features

  • Competitive double-antigen sandwich-based enzyme-linked immunosorbent assay
  • Specific detection of neutralization antibody
  • The microplate is coated with human ACE2 protein
  • No need for secondary antibody

Benefits

  • Highly compatible — No need for special experimental conditions and equipment
  • High-scalability — Ramp up testing capacity with 96-well plates
  • Fast TAT — Samples to results in 1.5 hour
  • Ease to operate — Mature test technology and all-inclusive with pre-mixed reagents
  • Easy interpretation — Analysis of one target with well-defined controls

Specifications 

  • 96 tests per kit
  • Human serum or plasma specimens only
  • Applicable instrument: Single or dual wavelength microplate reader with 450 nm or 450 nm/630 nm filter only
  • Reagents stable for 12 months at 2-8°C without freezing

Related Information

* Instructions for Use

* Product Flyer

* Frequently Asked Questions (FAQ)

Contact Us

* Request a quote and your BGI representative will reply to you within 24 hours.

Quick Contact